Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort
Christoph Molnar, Almut Scherer, Xenofon Baraliakos, et al.
Annals of the Rheumatic Diseases (2017) Vol. 77, Iss. 1, pp. 63-69
Open Access | Times Cited: 237

Showing 1-25 of 237 citing articles:

Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison
Joy Feld, Vinod Chandran, Nigil Haroon, et al.
Nature Reviews Rheumatology (2018) Vol. 14, Iss. 6, pp. 363-371
Closed Access | Times Cited: 180
Treatment of axial spondyloarthritis: an update
Abhijeet Danve, Atul Deodhar
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 4, pp. 205-216
Closed Access | Times Cited: 92
IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis
Sungsin Jo, Sung Eun Wang, Young Lim Lee, et al.
Arthritis Research & Therapy (2018) Vol. 20, Iss. 1
Open Access | Times Cited: 145
Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria
Fabian Proft, Denis Poddubnyy
Therapeutic Advances in Musculoskeletal Disease (2018) Vol. 10, Iss. 5-6, pp. 129-139
Open Access | Times Cited: 130
Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis
Désirée van der Heijde, J. Braun, Atul Deodhar, et al.
Lara D. Veeken (2018) Vol. 58, Iss. 3, pp. 388-400
Open Access | Times Cited: 128
Distinguishing rheumatoid arthritis from psoriatic arthritis
Joseph F. Merola, Luis R. Espinoza, Roy Fleischmann
RMD Open (2018) Vol. 4, Iss. 2, pp. e000656-e000656
Open Access | Times Cited: 122
Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial
Désirée van der Heijde, Xenofon Baraliakos, Kay‐Geert Hermann, et al.
Annals of the Rheumatic Diseases (2018) Vol. 77, Iss. 5, pp. 699-705
Open Access | Times Cited: 118
Multiple‐attribute group decision‐making method of linguisticq‐rung orthopair fuzzy power Muirhead mean operators based on entropy weight
Пэйдэ Лю, Weiqiao Liu
International Journal of Intelligent Systems (2019) Vol. 34, Iss. 8, pp. 1755-1794
Open Access | Times Cited: 103
Axial spondyloarthritis: new advances in diagnosis and management
Christopher T. Ritchlin, Iannis E. Adamopoulos
BMJ (2021), pp. m4447-m4447
Closed Access | Times Cited: 102
TNF-α-mediated m6A modification of ELMO1 triggers directional migration of mesenchymal stem cell in ankylosing spondylitis
Zhongyu Xie, Wenhui Yu, Zheng Guan, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 80
Osteoimmunological insights into the pathogenesis of ankylosing spondylitis
Lifei Liu, Yu Yuan, Shihua Zhang, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 9, pp. 6090-6100
Closed Access | Times Cited: 56
Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases
Boglárka Soós, Ágnes Szentpétery, Hennie G. Raterman, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 5, pp. 249-257
Closed Access | Times Cited: 42
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head‐to‐Head Randomized Phase IIIb Study
Xenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 8, pp. 1278-1287
Open Access | Times Cited: 14
Sacroiliac radiographic progression over 10 years in axSpA: data from the DESIR inception cohort
Anna Moltó, Clementina López‐Medina, Alexandre Sepriano, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 7, pp. 858-864
Closed Access | Times Cited: 11
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial
Fabian Proft, Murat Torğutalp, Burkhard Muche, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 5, pp. 599-607
Open Access | Times Cited: 10
A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis
Anna Deminger, Eva Klingberg, Mats Geijer, et al.
Arthritis Research & Therapy (2018) Vol. 20, Iss. 1
Open Access | Times Cited: 72
Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence
Bon San Koo, Ji Seon Oh, Seo Young Park, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 10, pp. 1327-1332
Open Access | Times Cited: 68
Effect of Therapy on Radiographic Progression in Axial Spondyloarthritis: A Systematic Review and Meta‐Analysis
Paras Karmacharya, Alí Duarte‐García, Maureen Dubreuil, et al.
Arthritis & Rheumatology (2020) Vol. 72, Iss. 5, pp. 733-749
Open Access | Times Cited: 62
The advent of IL-17A blockade in ankylosing spondylitis: secukinumab, ixekizumab and beyond
Sayam Dubash, Charlie Bridgewood, Dennis McGonagle, et al.
Expert Review of Clinical Immunology (2018) Vol. 15, Iss. 2, pp. 123-134
Open Access | Times Cited: 60
Treatment strategies in axial spondyloarthritis: what, when and how?
G. Fragoulis, Stefan Siebert
Lara D. Veeken (2020) Vol. 59, Iss. Supplement_4, pp. iv79-iv89
Open Access | Times Cited: 52
Impact of Tumor Necrosis Factor Inhibitor Versus Nonsteroidal Antiinflammatory Drug Treatment on Radiographic Progression in Early Ankylosing Spondylitis: Its Relationship to Inflammation Control During Treatment
Jun Won Park, Min Jung Kim, Jeong Seok Lee, et al.
Arthritis & Rheumatology (2018) Vol. 71, Iss. 1, pp. 82-90
Open Access | Times Cited: 54
The role of imaging in the diagnosis and management of axial spondyloarthritis
Walter P. Maksymowych
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 11, pp. 657-672
Closed Access | Times Cited: 54
Langfassung zur S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen, Update 2019
Uta Kiltz, Joseph M. Braun, Annette Becker, et al.
Zeitschrift für Rheumatologie (2019) Vol. 78, Iss. S1, pp. 3-64
Open Access | Times Cited: 52
Structural progression in axial spondyloarthritis
K. Aouad, Nelly Ziadé, Xenofon Baraliakos
Joint Bone Spine (2019) Vol. 87, Iss. 2, pp. 131-136
Closed Access | Times Cited: 51
Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review
Xenofon Baraliakos, Lianne S. Gensler, Salvatore D’Angelo, et al.
Therapeutic Advances in Musculoskeletal Disease (2020) Vol. 12
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top